Who Exports Aspirin from India — 327 Suppliers Behind a $37.8M Market
India's aspirin export market is supplied by 327 active exporters who collectively shipped $37.8M across 3,422 shipments. RECKITT BENCKISER (INDIA) PRIVATE LIMITED leads with a 9.9% market share, followed by CIPLA LIMITED and RECKITT BENCKISER INDIA PRIVATE LIMITED. The top 5 suppliers together control 32.3% of total export value, reflecting a moderately competitive market structure.
Top Aspirin Exporters from India — Ranked by Export Value
RECKITT BENCKISER (INDIA) PRIVATE LIMITED is the leading aspirin exporter from India, holding a 9.9% share of the $37.8M market across 3,422 shipments from 327 exporters. The top 5 suppliers — RECKITT BENCKISER (INDIA) PRIVATE LIMITED, CIPLA LIMITED, RECKITT BENCKISER INDIA PRIVATE LIMITED, ADCOCK INGRAM LIMITED, TRUECARE BIOMEDIX — collectively control 32.3% of total export value, indicating a competitive market. Individual shares are: RECKITT BENCKISER (INDIA) PRIVATE LIMITED (9.9%), CIPLA LIMITED (6.5%), RECKITT BENCKISER INDIA PRIVATE LIMITED (5.8%), ADCOCK INGRAM LIMITED (5.1%), TRUECARE BIOMEDIX (5.0%).
Top Aspirin Exporters from India
Ranked by export value · 327 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | RECKITT BENCKISER (INDIA) PRIVATE LIMITED ASPIRIN TABLETS 75MG 1X28SASPIRIN TABLETS 75MG 1X28S 207643 PASPIRIN 75MG TABRUDIPHARM/UK | $3.8M | 2 | 9.9% |
| 2 | CIPLA LIMITED ETHICS ASPIRIN ENTERIC COATED 100 MG TABETHICS ASPIRIN ENTERIC COATED 100MG TABLAPOHEALTH ASPIRIN SOLUBLE 300 MG TABLET | $2.5M | 2 | 6.5% |
| 3 | RECKITT BENCKISER INDIA PRIVATE LIMITED ASPIRIN TABLETS 75MG 1X28SASPIRIN TABLETS 75MG 1X28S 207643 PASPIRIN 75MG TABRUDIPHARM/UK | $2.2M | 1 | 5.8% |
| 4 | ADCOCK INGRAM LIMITED | $1.9M | 1 | 5.1% |
| 5 | TRUECARE BIOMEDIX ASPIRIN-ER DIPYRIDAMOLE CAP 25/200MG 60ASPIRIN/DIPYRIDAMOLE ER CAP 25/200MG 60PO NO -4500055370 | $1.9M | 1 | 5.0% |
| 6 | J B CHEMICALS AND PHARMACEUTICALS LIMITED CLOPIDOQREL 75 MG + ASPIRIN 100 MG CAPSUASPIRIN-ER DIPYRIDAMOLE CAP 25/200MG 60ASPIRIN/DIPYRIDAMOLE ER CAP 25/200MG 60PO NO -4500055370 | $1.7M | 2 | 4.5% |
| 7 | ELYSIUM PHARMACEUTICALS LTD ASPIRIN-ER DIPYRIDAMOLE CAP 25/200MG 60ASPIRIN/DIPYRIDAMOLE ER CAP 25/200MG 60PO NO -4500055370 | $1.6M | 1 | 4.1% |
| 8 | PAR FORMULATIONS PRIVATE LIMITED CLOPIDOQREL 75 MG + ASPIRIN 100 MG CAPSUASPIRIN-ER DIPYRIDAMOLE CAP 25/200MG 60ASPIRIN/DIPYRIDAMOLE ER CAP 25/200MG 60PO NO -4500055370 | $1.5M | 1 | 4.0% |
| 9 | SRI KRISHNA PHARMACEUTICALS LIMITED ASPIRIN GRANULES DC 90%[KRISOASP-90M]ASPIRIN GRANULES DC 90%ASPIRIN GRANULES DC GRADE)[KRISOASP-90M] | $1.3M | 4 | 3.4% |
| 10 | DR.REDDY'S LABORATORIES LTD ASPIRIN-ER DIPYRIDAMOLE CAP 25/200MG 60ASPIRIN/DIPYRIDAMOLE ER CAP 25/200MG 60PO NO -4500055370 | $1.3M | 1 | 3.4% |
| 11 | AJANTA PHARMA LIMITED | $1.2M | 5 | 3.3% |
| 12 | MEDREICH LIMITED APOHEALTH ASPIRIN SOLUBLE 300 MG TABLETASPIRIN TABLETS 75MG 1X28SASPIRIN ENTERIC COATED TABLETS 100MG (AP | $1.2M | 4 | 3.2% |
| 13 | INTAS PHARMACEUTICALS LIMITED ASPIRIN TABLETS 75MG 1X28SASPIRIN TABLETS 75MG 1X28S 207643 PASPIRIN 75MG TABRUDIPHARM/UK | $1.2M | 4 | 3.1% |
| 14 | GRANULES INDIA LIMITED ASPIRIN-ER DIPYRIDAMOLE CAP 25/200MG 60ASPIRIN/DIPYRIDAMOLE ER CAP 25/200MG 60PO NO -4500055370 | $1.1M | 1 | 2.9% |
| 15 | ATOZ PHARMACEUTICALS PRIVATE LIMITED CLOPIDOQREL 75 MG + ASPIRIN 100 MG CAPSUACETYLSALICYLIC ACID 300MG TACETYLSALICYLIC ACID 300MG TAB | $897.7K | 2 | 2.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Aspirin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| RECKITT BENCKISER (INDIA) PRIVATE LIMITED | Not Listed | Unknown | Yes | Not Available | MHRA issued EU GMP certificate on 26/11/2024 for Mysore facility. (cms.mhra.gov. |
| DR. REDDY'S LABORATORIES LTD | Not Listed | Yes | Unknown | Not Available | WHO-GMP certified as of February 2015. |
| J B CHEMICALS AND PHARMACEUTICALS LIMITED | Not Listed | Yes | Unknown | Not Available | WHO-GMP certified as of February 2015. |
| CIPLA LIMITED | Not Listed | Yes | Unknown | Not Available | WHO-GMP certified as of February 2015. |
| AJANTA PHARMA LIMITED | Not Listed | Yes | Unknown | Not Available | WHO-GMP certified as of February 2015. |
| MEDREICH LIMITED | Not Listed | Yes | Unknown | Not Available | WHO-GMP certified as of February 2015. |
| INTAS PHARMACEUTICALS LIMITED | Not Listed | Yes | Unknown | Not Available | WHO-GMP certified as of February 2015. |
| GRANULES INDIA LIMITED | Not Listed | Yes | Unknown | Not Available | WHO-GMP certified as of February 2015. |
| ATOZ PHARMACEUTICALS PRIVATE LIMITED | Not Listed | Yes | Unknown | Not Available | WHO-GMP certified as of February 2015. |
TransData Nexus reviewed the regulatory standing of 9 leading Aspirin exporters from India. 0 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Aspirin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts numerous pharmaceutical companies specializing in the manufacturing of APIs, which are essential components in drug formulations. This concentration of API manufacturers makes Hyderabad a critical node in the supply chain for drugs like aspirin.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to a significant number of pharmaceutical units, contributing substantially to India's pharmaceutical output. Companies in this cluster are involved in the production of finished dosage forms, including aspirin tablets, catering to both domestic and international markets.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a vital export gateway for India's pharmaceutical products. With its proximity to major ports and well-established infrastructure, this cluster facilitates the efficient export of pharmaceuticals, including aspirin, to global markets. The region's strategic location enhances India's position as a leading exporter of generic medicines.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, largely due to favorable tax incentives. This cluster attracts numerous pharmaceutical companies, contributing to the production of various drugs, including aspirin. The region's growth underscores the impact of policy incentives on the pharmaceutical industry's expansion.
5Sourcing Recommendations
- Engage with API Manufacturers in Hyderabad: Collaborate with API producers in Hyderabad to secure a reliable supply of high-quality aspirin APIs.
- Partner with Formulation Units in Gujarat: Establish partnerships with formulation manufacturers in the Ahmedabad-Vadodara region to access a diverse range of aspirin products.
- Leverage Export Facilities in Mumbai-Thane-Raigad: Utilize the export infrastructure in the Mumbai-Thane-Raigad area to streamline the distribution of aspirin to international markets.
- Consider Manufacturing in Baddi-Nalagarh: Explore manufacturing opportunities in the Baddi-Nalagarh cluster to benefit from tax incentives and cost-effective production.
By strategically engaging with these pharmaceutical clusters, companies can optimize their supply chain for aspirin, ensuring quality production and efficient distribution.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Aspirin exporters from India
RECKITT BENCKISER (INDIA) PRIVATE LIMITED — GSTIN status suspended
The Goods and Services Tax Identification Number (GSTIN) for RECKITT BENCKISER (INDIA) PRIVATE LIMITED was suspended in August 2024. - IMPACT: Potential disruption in domestic operations; export activities may be affected.
Impact: Potential disruption in domestic operations; export activities may be affected.
RECKITT BENCKISER INDIA PRIVATE LIMITED — GSTIN status active
As of December 2024, RECKITT BENCKISER INDIA PRIVATE LIMITED's GSTIN remains active, indicating compliance with tax regulations. - IMPACT: Stable regulatory status supports uninterrupted export operations.
Impact: Stable regulatory status supports uninterrupted export operations.
RECKITT BENCKISER (INDIA) PRIVATE LIMITED — GSTIN status active
By March 2025, RECKITT BENCKISER (INDIA) PRIVATE LIMITED's GSTIN is active, reflecting compliance with tax obligations. - IMPACT: Active GSTIN status facilitates smooth export processes.
Impact: Active GSTIN status facilitates smooth export processes.
Common Questions — Aspirin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which aspirin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, RECKITT BENCKISER (INDIA) PRIVATE LIMITED leads with 268 recorded shipments worth $3.8M. CIPLA LIMITED (240 shipments) and RECKITT BENCKISER INDIA PRIVATE LIMITED (86 shipments) are also established high-volume exporters.
Q How many aspirin manufacturers are there in India?
India has 327 active aspirin exporters with a combined export market of $37.8M across 3,422 shipments to 121 countries. The top 5 suppliers hold 32.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for aspirin from India?
Average FOB unit price: $7.83 per unit, ranging from $0.00 to $425.49. Average shipment value: $11.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 327 verified Indian exporters of Aspirin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 3,422 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 121 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,422 Verified Shipments
327 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists